Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
49%
OVERLAP
BY WEIGHT
18
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
75%
ALSO IN FBT
FBT
31
HOLDINGS
60%
ALSO IN BBH
SECTOR DRIFT (BBH minus FBT)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 6.4% | 4.7% | 4.7% |
 |
ARGENX SE ADR | 5.6% | 4.0% | 4.0% |
|
GILEAD SCIENCES INC | 13.8% | 3.7% | 3.7% |
|
REGENERON PHARMACEUTICALS | 5.3% | 3.4% | 3.4% |
|
AMGEN INC | 15.7% | 3.3% | 3.3% |
BBH Overweight Relative to FBT
|
AMGEN INC | 12.4% |
|
GILEAD SCIENCES INC | 10.1% |
|
VERTEX PHARMACEUTICALS INC | 5.7% |
|
IQVIA HOLDINGS INC | 5.0% |
|
INSMED INC | 3.8% |
 |
ICON PLC | 3.4% |
|
REGENERON PHARMACEUTICALS | 1.9% |
|
ALNYLAM PHARMACEUTICALS INC | 1.7% |
|
BIO-TECHNE CORPORATION | 1.7% |
|
QIAGEN NV | 1.7% |
BBH Underweight Relative to FBT
|
ACADIA PHARMACEUTICALS INC | -4.0% |
|
HALOZYME THERAPEUTICS INC | -3.7% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.5% |
|
UNITED THERAPEUTICS CORP | -3.5% |
|
VERACYTE INC | -3.4% |
|
CORCEPT THERAPEUTICS INC | -3.4% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
|
KRYSTAL BIOTECH, INC. | -3.2% |
|
SAREPTA THERAPEUTICS INC | -3.0% |
|
ALKERMES PLC | -3.0% |